MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
1-866-531-8896
Pfizer Inc Emergency telephone
24 Hours
Pfizer Animal Health Hours of operation
1-800-366-5288
235 East 42nd Street Telephone
New York, NY 10017
Trade names FluSure RTU
Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus
Product name
Veterinary vaccine
Description
SECTION 2 - COMPOSITION
Ingredient CAS Number Amount
Swine Influenza Virus A, strain H1N1 Not assigned Trade secret
Swine Influenza Virus A, strain H3N2 Not assigned Trade secret
Amphigen base Not assigned Trade secret
EDTA 60-00-4 Trade secret
Gentamicin* 1403-66-3 Trade secret
Merthiolate (as mercury)* 54-64-8 Trace
Water, purified 7732-18-5 >90%
*Hazardous
Note: Ingredient(s) indicated as hazardous have been assessed under standards
for workplace safety. Whether or not they are specifically referred to
elsewhere in this document is dependent upon the potency and
concentration in the product.
SECTION 3 - HAZARDS IDENTIFICATION
Not applicable
Signal word
Not applicable
Statements of hazard
None known; however, direct contact with any foreign material may cause
Eye effects
eye irritation.
None known
Skin effects
An Occupational Exposure Limit has been established for one or more of
Inhalation effects
the ingredients (see Section 8).
None known
Ingestion effects
19A5.24 - Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus Pfizer Inc.
Revision date: 07/11/02, Version: 1.0.0 Page 1 of 5
SECTION 3 - HAZARDS IDENTIFICATION ... continued
Other potential health In the event of accidental injection, an allergic reaction may occur. If an
effects allergic reaction occurs, the worker should be removed to the nearest
emergency room and the appropriate therapy instituted.
Route of entry Skin contact, inhalation, accidental injection
This document has been prepared in accordance with standards for
NOTE:
workplace safety, which require the inclusion of all known hazards of the
product or its ingredients regardless of the potential risk. The
precautionary statements and warnings included may not apply in all
cases. Your needs may vary depending upon the potential for exposure in
your workplace.
SECTION 4 - FIRST AID MEASURES
Skin Wash skin with soap and water. If irritation occurs or persists, get medical
attention.
Eyes Immediately flush eyes with water for at least 15 minutes. If irritation
occurs or persists, get medical attention.
Inhalation Remove to fresh air. If not breathing, give artificial respiration. Get
medical attention immediately.
Ingestion Get medical attention. Do not induce vomiting unless directed by medical
personnel. Never give anything by mouth to an unconscious person.
SECTION 5 - FIRE FIGHTING MEASURES
General hazard This product is a nonflammable aqueous solution. This material is not
expected to support combustion.
Dike and collect water used to fight fire.
Fire fighting instructions
As for primary cause of fire.
Extinguishing media
Non-flammable
Flash point
Not known
Hazardous combustion
products
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
General
Small spill Contain the source of the spill or leak. Use non-combustible absorbent
material to wipe up spill and place in a sealed container for disposal. Clean
spill area thoroughly. Prevent discharge to drains.
19A5.24 - Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus Pfizer Inc.
Revision date: 07/11/02, Version: 1.0.0 Page 2 of 5
SECTION 6 - ACCIDENTAL RELEASE MEASURES ... continued
Large spill Use appropriate containment to avoid environmental contamination. Dike,
pump, or use non-combustible material to absorb spill; then place in a
labeled container for disposal. Close container and move it to a secure
holding area. Prevent runoff from entering drains, sewers, or streams.
SECTION 7 - HANDLING AND STORAGE
General handling Use with adequate ventilation. Avoid contact with eyes, skin and clothing.
Avoid breathing dust, vapor or mist.
Store under refrigeration in closed container.
Storage conditions
2-7掳C
Temperature range
for storage
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure limits
Compound Issuer Type OEL
Merthiolate (as mercury) OSHA TWA-8 Hr 0.01 mg/m鲁 (skin)
ACGIH TWA-8 Hr 0.1 mg/m鲁 (skin)
See exposure limits for component (s) listed above.
Exposure information
Engineering controls should be used as the primary means to control
Ventilation
exposures. Exposure monitoring may be necessary to determine
requirements.
In the event of a spill where the applicable Occupational Exposure Limit
Respiratory protection
(OEL) may be exceeded, wear an appropriate respirator with a protection
factor sufficient to control exposures below the OEL.
Safety glasses or goggles are recommended if eye contact is possible.
Eye protection
Wear protective clothing when working with large quantities.
Skin protection
Wear impervious gloves if skin contact is possible.
Hand protection
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
No data available
Physical form
No data available
Color
Mixture
Molecular weight
Mixture
Molecular formula
7.0 +/- 1.5 standard pH units
pH
19A5.24 - Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus Pfizer Inc.
Revision date: 07/11/02, Version: 1.0.0 Page 3 of 5
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ... continued
>100掳C
Boiling point
Not applicable
Melting point
No data available
Density
Expected to be negligible
Vapor pressure
Components are soluble in water
Water solubility
No data available
Solvent solubility
1.0 +/-0.2
Specific gravity
SECTION 10 - STABILITY AND REACTIVITY
This mixture is stable
Reactivity
Store at 2-7掳C. Prolonged exposure to higher temperatures may adversely
Conditions to avoid
affect potency. Do not freeze.
This material can be denatured or inactivated by a variety of organic
Incompatibilities
solvents, salts or heavy metals.
None expected under normal conditions.
Hazardous
decomposition
products
Will not occur
Hazardous
polymerization
SECTION 11 - TOXICOLOGY INFORMATION
The antigens included in this product are non-infectious. All have been
Toxicology summary
prepared from killed or inactivated preparations of microorganisms.
Acute toxicity
No data available
Eye
No data available
Skin
No data available
Inhalation
No data available
Ingestion
No data available
Mutagenicity
This product contains merthiolate which is considered to be a skin
Sensitization
sensitizer.
No data available
Subchronic effects
19A5.24 - Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus Pfizer Inc.
Revision date: 07/11/02, Version: 1.0.0 Page 4 of 5
SECTION 11 - TOXICOLOGY INFORMATION ... continued
No data available
Chronic effects/
carcinogenicity
None of the components of this formulation are listed as a carcinogen by
Carcinogen status
IARC, NTP or OSHA.
Not considered to be a reproductive hazard.
Reproductive effects
SECTION 12 - ECOLOGICAL INFORMATION
The environmental characteristics of this material have not been fully
Environmental overview
evaluated. Releases to the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Observe all local and national regulations when disposing of this material.
Disposal procedure
This product contains trace quantities of mercury and may qualify as a
RCRA Hazardous Waste. Status should be confirmed using the EPA
Toxicity Characteristic Leaching Procedure (TCLP).
SECTION 14 - TRANSPORTATION INFORMATION
Not regulated for transport under USDOT, EUADR, IATA, or IMDG
General shipping
regulations.
instructions
SECTION 15 - REGULATORY INFORMATION
Not classified
EU Classification
California Proposition 65 Mercury (as Merthiolate); Aminoglycosides (Gentamicin)
This product has been classified in accordance with the hazard criteria of
Canadian WHMIS
the CPR and the MSDS contains all of the information required by the
CPR.
SECTION 16 - OTHER
Disclaimer Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate. While Pfizer provides this information
in good faith, it does not expressly or impliedly warrant its accuracy.
19A5.24 - Swine Influenza Vaccine, H1N1 and H3N2, Killed Virus Pfizer Inc.
Revision date: 07/11/02, Version: 1.0.0 Page 5 of 5
|